Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (271 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 18 Dec 2024 – 20 Aug 2026, limited by Tata BSE Select Business Groups Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Tata BSE Select Business Groups Index Fund | Nifty 500 |
|---|---|---|
| 18 Dec 2024 | ₹100.00 | ₹100.00 |
| 07 Feb 2025 | ₹95.50 | ₹94.38 |
| 30 Mar 2025 | ₹93.54 | ₹93.05 |
| 20 May 2025 | ₹99.26 | ₹98.48 |
| 09 Jul 2025 | ₹102.26 | ₹102.72 |
| 29 Aug 2025 | ₹97.82 | ₹97.94 |
| 19 Oct 2025 | ₹103.45 | ₹102.89 |
| 09 Dec 2025 | ₹104.93 | ₹102.54 |
| 29 Jan 2026 | ₹103.48 | ₹100.87 |
| 21 Mar 2026 | ₹95.83 | ₹93.00 |
| 10 May 2026 | ₹105.80 | ₹100.79 |
| 30 Jun 2026 | ₹102.37 | ₹100.27 |
| 20 Aug 2026 | ₹105.13 | ₹102.52 |
| Metric | Tata · Regular · IDCW NAV ₹10.29 Very High risk ★★★☆☆ 1Y | Category median Index Funds · 271 funds |
|---|---|---|
| +4.24% | +4.72% | |
| — | +7.52% | |
| — | +8.28% | |
| — | +9.00% | |
| +3.04% | +7.27% | |
| +5.61% | — | |
| — | +7.88% | |
| — | +10.94% | |
| — | +9.63% | |
| Risk | ||
| 16.39% | 13.54% | |
| -0.14 | 0.11 | |
| -0.19 | 0.15 | |
| -15.21% | -15.67% | |
| Nifty 500 | — | |
| — | -0.05% | |
| — | 1.00 | |
| — | 101.3% | |
| — | 99.5% | |
| 1.07% | 0.88% | |
| ₹236.48Cr | ₹181.49Cr | |
| 0.25% | — | |
| None | — | |
| ₹100 | — | |
| ₹5.00K | — | |
| 34% | 38% | |
| Rakesh Prajapati · 1.7y | — | |
| 18 Dec 2024 | — | |
| 30 | — | |
| 70.2% | — | |
| 0.1% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.